Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00070707
Status:
COMPLETED
Last Update Posted:
2022-02-07
First Post:
2003-10-07
Brief Title:
Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis SAR and Concomitant Asthma P03280
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
Efficacy and Safety of Nasonex vs Placebo in Subjects With SAR and Concomitant Asthma
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare mometasone nasal spray to placebo in treating the nasal and asthma symptoms experienced by participants with seasonal allergic rhinitis SAR and concomitant asthma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MK-0887-064 | OTHER | Merck | None |